GILS stands up the first Scleroderma Units in Italy
Board and members of GILS, Italy, in agreement with the scientific committee, with some hospitals and Institutions will get some Scleroderma Units off the ground.
This Units, already working in UK and USA, offer a skill network to patients in need of diagnosis and therapeutic knowledge, within just one Centre highly specialized and able to make a team Unit.
Read the press release GILS stands up the first Scleroderma Units in Italy
Visit GILS at www.sclerodermia.net
news & events
Watch our highlights video showing some of our great achievements in 2022.
Are you living with diffuse scleroderma?
Would you like to be involved in a clinical study testing a new investigational drug for use in Diffuse Scleroderma?
If so, you may be eligible to take part in the DECODE Scleroderma Study
FESCA is proud to be a partner of a the new This is Living campaign launched last month by Boehringer Ingelheim.